Abstract (EN):
Neurodegenerative diseases confront mankind in a variety of
guises inducing chronic suffering and debilitation for a
significant percentage of the worldwide population. The quest
for new targets within cell machinery is one of the major
issues in this field of study. Apart from the major classic
targets in neuronal system a battery of new putative targets
has been proposed nowadays.
In fact, targeting mitochondria could be an effctive way to slow
the neurodegenerative disease progression and consequently
the ageing processes of the brain. Although the molecular
mechanisms responsible for mitochondria-mediated disease
processes are not yet fully elucidated, the oxidative stress
appears to be critical. The matrix space in mitochondria is the
intracellular compartment which is potentially the most active
in production of ROS and is the most vulnerable to ROS
damaging effects. In this context, the control of mitochondrial
redox processes is an attractive perspective and the
development of mitochondriotropic compounds is of great
importance in such an effort.
The development of phenolic antioxidants with natural or synthetic origin corresponds to a relevant research area,
particularly in obtention of chemical entities suitable to prevent
and/or treat diseases involving oxidative damage.
Benzoic and cinamic acids (e.g. sinapic, ferulic and caffeic
acids), flavonoids and coumarins, have been often used as
templates for the design and development of new antioxidants.
However, the majority of natural antioxidants, studied until the
date, had limited success. One of the reasons mentioned for
this limitation is related to the fact that the majority of natural
antioxidants are distributed throughout the body and only a
small fraction penetrates into the target sites (e.g. the
mitochondria).
The aim of our project is the design and synthesis of several
hydroxycinnamic antioxidant derivatives harbouring positive
charges at physiological pH (hence capable of mitochondrial
accumulation) that could be used as potent and selective
agents throughout specific targeting the mitochondria. Some
of the results obtained so far will be presented in this
communication.
Language:
Portuguese
Type (Professor's evaluation):
Scientific